Skip to main content

Xolremdi Side Effects

Generic name: mavorixafor

Medically reviewed by Drugs.com. Last updated on Dec 10, 2024.

Note: This document provides detailed information about Xolremdi.

Applies to mavorixafor: oral capsules Side Effects associated with mavorixafor. Some dosage forms listed on this page may not apply specifically to the brand name Xolremdi.

Applies to mavorixafor: oral capsules.

Side effects include:

Most common adverse effects (incidence >10% and at a frequency higher than placebo): thrombocytopenia, pityriasis, rash, rhinitis, epistaxis, vomiting, dizziness.

For healthcare professionals

Applies to mavorixafor: oral capsule.

General adverse events

The most common adverse reactions (10% or greater) were: thrombocytopenia, pityriasis, rash, rhinitis, epistaxis, vomiting and dizziness.[Ref]

Gastrointestinal

Dermatologic

Hematologic

Cardiovascular

Nervous system

Respiratory

References

1. (2024) "Product Information. Xolremdi (mavorixafor)." X4 Pharmaceuticals, Inc.

Further information

Xolremdi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.